Center-Authored Papers

Filters: Author is Goodman, Phyllis  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Ankerst DP, Till C, Boeck A, Goodman P, Tangen CM, Feng Z, Partin AW, Chan DW, Sokoll L, Kagan J et al..  2013.  The impact of prostate volume, number of biopsy cores, and AUA symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial Risk Calculator.. The Journal of urology. Abstract
B
Brasky TM, Till C, White E, Neuhouser ML, Song X, Goodman P, Thompson IM, King IB, Albanes D, Kristal AR.  2011.  Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.. American journal of epidemiology. 173(12):1429-39. Abstract
C
Chen F, He J, Zhang J, Chen GK, Thomas V, Ambrosone CB, Bandera EV, Berndt SI, Bernstein L, Blot WJ et al..  2015.  Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults.. PloS one. 10(6):e0131106. Abstract
K
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, Thompson IM.  2008.  Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 167(8):925-34. Abstract
Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM.  2010.  Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.. American journal of epidemiology. 172(5):566-77. Abstract
Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA.  2017.  Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).. JAMA neurology. Abstract
N
Neuhouser ML, Till C, Kristal AR, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M.  2010.  Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.. Cancer prevention research (Philadelphia, Pa.). 3(3):279-89. Abstract
S
Schenk JM, Calip GS, Tangen CM, Goodman P, Parsons KJ, Thompson IM, Kristal AR.  2012.  Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.. American journal of epidemiology. 176(2):156-63. Abstract
Song YJ, Tangen CM, Goodman P, Parnes HL, Lucia SM, Thompson IM, Kristal AR.  2008.  Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment.. The Prostate. 68(3):281-6. Abstract
T
Thompson IM, Tangen CM, Ankerst DP, Chi C, Lucia SM, Goodman P, Parnes H, Coltman CA.  2008.  The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy.. The Journal of urology. 180(2):544-7. Abstract